140 related articles for article (PubMed ID: 35646176)
21. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
22. Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of the urinary bladder.
Takashi M; Murase T; Kinjo T; Mitsuya H; Nagura H
Urol Int; 1987; 42(3):170-5. PubMed ID: 3303592
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum.
Davidson BR; Sams VR; Styles J; Dean C; Boulos PB
Gut; 1989 Sep; 30(9):1260-5. PubMed ID: 2806995
[TBL] [Abstract][Full Text] [Related]
25. The Significance of ERG and Androgen Receptor Expression in Adenocarcinoma Prostate.
Husain I; Sagar P; Shukla S; Babu S; Singhai A; Sankhwar SN; Husain N
Kathmandu Univ Med J (KUMJ); 2018 Oct.-Dec.; 16(64):277-280. PubMed ID: 31729338
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.
Chan TY; Mikolajczyk SD; Lecksell K; Shue MJ; Rittenhouse HG; Partin AW; Epstein JI
Urology; 2003 Jul; 62(1):177-81. PubMed ID: 12837462
[TBL] [Abstract][Full Text] [Related]
27. Adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of minor salivary glands: a comparative immunohistochemical study using the epithelial membrane and carcinoembryonic antibodies.
Epivatianos A; Iordanides S; Zaraboukas T; Antoniades D
Oral Dis; 2005 May; 11(3):175-80. PubMed ID: 15888109
[TBL] [Abstract][Full Text] [Related]
28. Expression of cysteine protease protein 32 in prostatic adenocarcinoma correlates with tumor grade.
Anwar S; Ambros RA; Jennings TA; Ross JS; Beza A; Mian B; Nazeer T
Arch Pathol Lab Med; 2004 Jun; 128(6):649-52. PubMed ID: 15163235
[TBL] [Abstract][Full Text] [Related]
29. The monoclonal antibody 7E12H12 can differentiate primary adenocarcinoma of the bladder and prostate.
Pantuck AJ; Murphy DP; Amenta PS; Das KM; Cummings KB; Weiss RE
Br J Urol; 1998 Sep; 82(3):426-30. PubMed ID: 9772883
[TBL] [Abstract][Full Text] [Related]
30. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of immunohistochemical marker prostein for evaluation of primary and metastatic prostatic carcinomas.
Garudadri G; Rao BV; Sundaram C; Fonseca D; Murthy SS; Sharma R; Rao TS
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S18-S24. PubMed ID: 32108621
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.
Bamias A; Chorti M; Deliveliotis C; Trakas N; Skolarikos A; Protogerou B; Legaki S; Tsakalou G; Tamvakis N; Dimopoulos MA
Urology; 2003 Aug; 62(2):368-73. PubMed ID: 12893366
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical determination of p53 protein in prostatic cancer and prostatic intraepithelial neoplasms.
Yaman O; Ozdiler E; Orhan D; Sak SD; Baltaci S; Tulunay O; Göğüş O
Urol Int; 1997; 58(4):199-202. PubMed ID: 9253117
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical study of androgen receptor in adenocarcinoma of the human prostatic cancer].
Yoshikawa H; Ikeuchi T; Kai Y
Nihon Hinyokika Gakkai Zasshi; 1996 Jul; 87(7):956-63. PubMed ID: 8776961
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.
Fernández-Martínez AB; Carmena MJ; Arenas MI; Bajo AM; Prieto JC; Sánchez-Chapado M
Histol Histopathol; 2012 Aug; 27(8):1093-101. PubMed ID: 22763881
[TBL] [Abstract][Full Text] [Related]
36. BRCA1-associated protein 1 expression and prognostic role in prostate adenocarcinoma.
Oh H; Lee YJ; Kang SG; Ahn B; Kim E; Chae YS; Lee Y; Lee JH; Kim CH
Investig Clin Urol; 2020 Mar; 61(2):166-172. PubMed ID: 32158967
[TBL] [Abstract][Full Text] [Related]
37. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature.
Murugan P; Siddaraju N; Habeebullah S; Basu D
Indian J Pathol Microbiol; 2009; 52(2):175-81. PubMed ID: 19332905
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma.
McLoughlin J; Foster CS; Price P; Williams G; Abel PD
Br J Urol; 1993 Jul; 72(1):92-7. PubMed ID: 7511972
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma.
Radi DA; Abd-Elazeem MA
Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
